Inactive Instrument

Other languages Mira IV Acquisition Corp Toronto S.E.

Equities

MRYp

CA60456Q1054

End-of-day quote Toronto S.E. Other stock markets
-	-

May. 15	Transcript : Profound Medical Corp. - Shareholder/Analyst Call
May. 14	Sector Update: Health Care Stocks Steady Premarket Tuesday	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Steady Premarket Tuesday	May. 14
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell	May. 14
Profound Medical Receives U.S. FDA 510(K) Clearance for Contour Assistant AI Module That Enables Creation of an Automated Tulsa Treatment Plan	May. 14
Profound Reports a Narrower First-Quarter Loss; Provides 2024 Revenue Guidance	May. 09
Profound Medical Corp. Provides Earnings Guidance for Full-Year 2024	May. 09
Profound Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07
Profound Medical Reports Q4 Net Loss of US$0.42 Per Share, Announces COO Appointment	Mar. 07
Profound Medical Corp. Enters into A Non-Exclusive Collaboration with Siemens Healthineers	Feb. 27
Profound Medical Up 1.9% In US After Hours As Announces Non-Brokered Private Placement	Jan. 16
Sector Update: Health Care Stocks Steady Premarket Thursday	Dec. 28
Wall Street in Consolidation Mode in Penultimate Session for 2023, Driving Muted Premarket Action for US Equity Futures	Dec. 28
Profound Medical Prices $20 Million Public Share Offering	Dec. 28
Profound Medical Plans Stock Offering; Shares Drop After-Hours	Dec. 27
Profound Medical Announces CMS Extension of Temporary 'Code' for Tulsa to ASC Setting	Nov. 03
Profound Medical Corp. Announces CMD Extension of Temporary Code for TULSA to ASC Setting	Nov. 03
Profound Medical Reports Q3 2023 Revenue of US$1.7 Million	Nov. 02
Profound Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Profound Medical Gets FDA Clearance for Tulsa-Pro Thermal Boost	23-09-25
Profound Medical Corp. Receives U.S. FDA 510(k) Clearance for TULSA-PRO Thermal Boost	23-09-25
Profound Medical Plans At-the-Market Offering of up to US$30 Million; Up Nearly 5%	23-09-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mira IV Acquisition Corp Toronto S.E.

Equities

MRYp

CA60456Q1054

Other languages

Filters